new cancer drugs approved by Health Canada

You may hear about new cancer drugs approved by Health Canada.

Zevalin (ibritumomab) and Bexxar (tositumomab) are for relapsed or refractory non-Hodgkin's lymphoma.

They are in a new class of drugs called radiolabelled monoclonal antibodies.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote